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The tumor microenvironment is acidic due to glycolytic cancer cell metabolism, hypoxia,
and deficient blood perfusion. It is proposed that acidosis in the tumor microenvironment
is an important stress factor and selection force for cancer cell somatic evolution. Acidic pH
has pleiotropic effects on the proliferation, migration, invasion, metastasis, and therapeutic
response of cancer cells and the function of immune cells, vascular cells, and other
stromal cells. However, the molecular mechanisms by which cancer cells and stromal cells
sense and respond to acidic pH in the tumor microenvironment are poorly understood. In
this article the role of a family of pH-sensing G protein-coupled receptors (GPCRs) in tumor
biology is reviewed. Recent studies show that the pH-sensing GPCRs, including GPR4,
GPR65 (TDAG8), GPR68 (OGR1), and GPR132 (G2A), regulate cancer cell metastasis and
proliferation, immune cell function, inflammation, and blood vessel formation. Activation
of the proton-sensing GPCRs by acidosis transduces multiple downstream G protein
signaling pathways. Since GPCRs are major drug targets, small molecule modulators
of the pH-sensing GPCRs are being actively developed and evaluated. Research on
the pH-sensing GPCRs will continue to provide important insights into the molecular
interaction between tumor and its acidic microenvironment and may identify new targets
for cancer therapy and chemoprevention.
Keywords: cancer, tumor microenvironment, acidosis, proton-sensing G protein-coupled receptors, GPR4, GPR65
(TDAG8), GPR68 (OGR1), GPR132 (G2A)
INTRODUCTION
Solid tumors consist of multiple cell types, such as cancer cells,
stromal cells, and immune cells, and a large assortment of extra-
cellular matrix proteins and chemical signals (Hanahan and
Weinberg, 2011). The interaction that stromal cells, immune cells,
and the extracellularmatrix have with cancer cells regulates tumor
growth and development. Because of insufficient blood perfusion,
hypoxia, inflammation, and glycolytic cell metabolism, the tumor
microenvironment has long been known as characteristically
acidic (Vaupel et al., 1989; Gatenby and Gillies, 2004; Cairns et al.,
2006; Yang et al., 2012). The unique glycolytic metabolism of can-
cer cells produces an excessive amount of lactic acid (Warburg,
1956). Consequently, the export of protons and lactic acid from
tumor cells into the extracellular space by acid-base regulators,
such as Na+/H+ exchangers and monocarboxylate transporters,
may lead to acidosis in the tumormicroenvironment (Izumi et al.,
2003; Boedtkjer et al., 2013). Under normal physiological con-
ditions the pH of blood and tissue is tightly controlled around
pH 7.4. However, in diseased tissues such as the tumor microen-
vironment a local pH range from 5.5 to 7.0 is not uncommon
(Vaupel et al., 1989; Gatenby and Gillies, 2004). Moreover, intra-
cellular pH of tumor cells is slightly alkaline in comparison to
the extracellular space, which has been demonstrated to facilitate
cell proliferation and tumor growth (Tannock and Rotin, 1989;
Vaupel et al., 1989; Griffiths, 1991; Griffiths et al., 2001; Webb
et al., 2011).
Acidosis in the tumor microenvironment may have many
effects on themalignancy and development of a tumor (Figure 1).
It has been proposed that exposure to chronic acidosis may
facilitate cancer cell clonal evolution by inducing chromoso-
mal instability, clastogenicity, and gene mutations (Morita et al.,
1992; Xiao et al., 2003). In addition, acidosis may contribute
to metastatic progression by degrading the extracellular matrix
(Rozhin et al., 1994; Brisson et al., 2012). On the other hand, aci-
dosis can be cytotoxic, inhibit cancer cell proliferation, and induce
stress response and apoptosis (Ohtsubo et al., 1997; Williams
et al., 1999; Putney and Barber, 2003; Smallbone et al., 2010).
Taken together, acidosis has been described as a defining hallmark
of the tumor microenvironment. However, the mechanisms by
which cancer cells, immune cells, and blood vessels sense acidosis
and respond to it are yet to be completely established but may be
advantageous for a more comprehensive understanding of tumor
biology.
There are several families of receptors and ion channels that
help cells sense extracellular acidosis (Holzer, 2009). In this
review we discuss a family of proton-sensing G protein-coupled
receptors (GPCRs) including GPR4, GPR65 (TDAG8), GPR68
(OGR1), and GPR132 (G2A). It has been reported that these
GPCRs are involved in cancer cell proliferation, apoptosis, metas-
tasis, angiogenesis, immune cell function, and inflammation
(Ludwig et al., 2003; Singh et al., 2007; Yang et al., 2007; Mogi
et al., 2009; Castellone et al., 2011; Chen et al., 2011; He et al.,
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FIGURE 1 | The acidic tumor microenvironment regulates the
proliferation, apoptosis, clonal evolution, and metastasis of cancer
cells and modulates inflammation, anti-tumor immunity, and
angiogenesis.
2011; Ren and Zhang, 2011; Wyder et al., 2011; Dong et al.,
2013).
ACIDOSIS AND TUMOR CELL FUNCTION
A number of studies have examined the acute and chronic effects
of acidosis on tumor cell gene expression, proliferation, apop-
tosis, and malignancy. In general, cells become stressed in a pH
range that deviates moderately from pH 7.4. When the pH range
of a tissue significantly falls outside of this category cell function
may be affected and apoptosis may be induced. Acute acidosis
may inhibit proliferation and increase apoptosis of tumor cells
(Ohtsubo et al., 1997; Williams et al., 1999; Putney and Barber,
2003; Smallbone et al., 2010). Chronically, however, acidosis can
act as a stressor and select for tumor cells that are resistant to
the acidic microenvironment (Moellering et al., 2008; Marino
et al., 2012; Wojtkowiak et al., 2012). The mechanism by which
tumor cells may overcome acidosis-associated cell death while
normal cells perish has been investigated. Autophagy, a catabolic
degradation process in which unnecessary organelles and vari-
ous proteins are recycled, has been described as a mechanism to
evade acidosis-related cell death (Marino et al., 2012; Wojtkowiak
et al., 2012). Tumor cells may develop chronic autophagy, which
allows for acidosis-resistant tumor cells to continue to survive and
proliferate (Marino et al., 2012; Wojtkowiak et al., 2012). In addi-
tion, several reports connect p53 activity to acidosis-mediated cell
death (Williams et al., 1999; Reichert et al., 2002). In tumor cells
with p53mutations acidosis-mediated cell death may be bypassed
and cell division may continue to take place, which confers a
survival advantage to some tumor cells (Williams et al., 1999;
Reichert et al., 2002).
The effects of acidosis on cancer development and progres-
sion are complex. They may be separated into acute and chronic
exposure related effects as the responses of tumor cells to these
conditions are diverse. It has been reported that chronically high
lactate in cervical cancers are correlated with a reduction in
patient survival (Walenta et al., 2000). In addition, several reports
have indicated that chronic systemic buffer therapy may reduce
tumor growth and metastasis in SCID or TRAMP mice indi-
cating that chronic acidosis may facilitate tumor growth and
metastasis (Ibrahim Hashim et al., 2011; Ibrahim-Hashim et al.,
2012). Acidosis has also been demonstrated to increase the secre-
tion of proteases such as cathepsin B in melanoma cells and
matrix metalloproteinase-9 (MMP-9) in human osteosarcoma
cells (Rozhin et al., 1994; Matsubara et al., 2013), which may
facilitate the degradation of extracellular matrix proteins and
subsequently accelerate tumor cell invasion. Acidosis has been
reported to increase aggressiveness in human melanoma cells. By
treating A-07, D-12, and T-22 human melanoma cells with media
buffered to pH 6.8, several proteins such as MMP-2, MMP-9,
cathepsin B, cathepsin L, VEGF-A, and IL-8 are upregulated and
contribute to increased experimental lungmetastasis post tail vein
injections in athymic nude mice (Rofstad et al., 2006).
On the other hand, acidosis has been reported to induce tumor
cell apoptosis, and inhibit cell proliferation and carcinogenesis
(Ohtsubo et al., 1997; Zanke et al., 1998; Williams et al., 1999;
Putney and Barber, 2003; Smallbone et al., 2010; Matsubara et al.,
2013). Episodic and transient acidosis is proposed to be a possi-
ble mechanism by which increased physical activity reduces the
risk of cancer incidence (Smallbone et al., 2010). It has been
reported there is decreased expression of glycolytic genes and
increased expression of the tricarboxylic acid (TCA) cycle and
electron transport genes in response to acute acidosis in breast
epithelial cells (Chen et al., 2008). The gene signature in response
to acute acidosis is correlated with a higher survival in breast
cancer patients. Furthermore, the response to acute acidosis in
prostate cancer cells has been reported to reduce the activa-
tion of the oncogene Akt (protein kinase B) (Chen et al., 2008),
which is upregulated in a variety of cancers and is important for
several processes such as glucose uptake, cell survival, and cell
proliferation.
In addition, acidosis in the tumor microenvironment may
affect the response of cancer cells to therapy. It has been demon-
strated that the efficacy of some chemotherapeutics is affected
under acidic pH in comparison to the physiological pH. Acidic
extracellular pH may also modulate the charge status of weak
acid and weak base chemotherapy drugs and therefore, influence
the uptake of these drugs across the cell membrane, in particu-
lar, reducing the uptake of weak base drugs and increasing the
uptake of weak acid drugs (Reichert et al., 2002; Cairns et al.,
2006; Gerweck et al., 2006).
ACIDOSIS AND THE INFLAMMATORY RESPONSE
The inflammatory response in the tumor microenvironment has
long been known to show both tumor promoting activity as
well as anti-tumor activity (Kim et al., 2007; Grivennikov et al.,
2010; Hanahan andWeinberg, 2011). How acidosis may affect the
activity of immune cells in the tumor microenvironment may be
highly valuable in the field of cancer biology and tumor immunol-
ogy. Inflammatory cells and mediators themselves may further
reduce the pH of the tumor microenvironment by increasing glu-
cose uptake and glycolysis as well as stimulating ATP-dependent
proton extrusion mechanisms (Grinstein et al., 1991; Imtiyaz
and Simon, 2010). Numerous studies indicate that acidosis has
multiple effects on the function and response of inflammatory
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mediators such as neutrophils, monocytes, macrophages, and
the complement pathways (Lardner, 2001; Martinez et al., 2006;
Jancic et al., 2012).
Acidosis induces the activation of neutrophils through the
PI3-kinase/Akt and ERK signaling pathways (Martinez et al.,
2006), and it also prompts the release of platelet-activating fac-
tor, a potent inflammatory activator, from human neutrophils
through the p38 mitogen-activated protein kinase (MAPK) path-
way (Owen et al., 2005). Neutrophils themselves may enhance
acidosis and hypoxia in the tumor microenvironment by increas-
ing oxygen consumption and subsequently emitting protons fol-
lowing respiratory burst (Van Zwieten et al., 1981; Borregaard
et al., 1984). Acidosis may also stimulate the release of IL-1β
from monocytes and TNF-α from resident alveolar macrophages
both of which are strong inflammatory mediators (Heming et al.,
2001; Jancic et al., 2012). Paradoxically, acidosis can also reduce
the inflammatory/immune response. In other reports the activ-
ity of natural killer (NK) as well as lymphokine-activated killer
(LAK) cells is reduced and the release of TNF-α, interferon-γ,
IL-10, IL-12 and transforming growth factor- β1(TGF-β1) is also
diminished by acidosis (Fischer et al., 2000; Muller et al., 2000).
Studies also showed that acidosis impairs cytolytic activity and
causes anergy of CD8+ T lymphocytes (Calcinotto et al., 2012).
The mechanisms by which inflammatory/immune cells sense aci-
dosis and respond to it may be of importance in the tumor
immunology and inflammation field as this is the environment
the immune cells function in.
ACIDOSIS AND BLOOD VESSELS
Blood vessels formed in the tumor microenvironment are charac-
terized by structural abnormalities, functional defects, and hyper-
permeability (Fukumura and Jain, 2007; Nagy et al., 2010). Due to
rapid tumor growth and an increased distance between vascula-
ture and cancer cells beyond the oxygen diffusion limit, the tumor
microenvironment is hypoxic and acidic (Gatenby and Gillies,
2004). Consequently, hypoxia and acidosis also regulate the gen-
eration of new blood vessels from pre-existing blood vessels, a
process known as angiogenesis.
Acidosis has been reported to inhibit angiogenesis in the aor-
tic ring vessel outgrowth model (Burbridge et al., 1999). In the
presence of vascular endothelial growth factor (VEGF) and basic
fibroblast growth factor (bFGF), however, this inhibitory effect
may be attenuated and angiogenesis may resume (Burbridge et al.,
1999). It has been shown that acidosis increases the expression of
VEGF and bFGF in endothelial cells (D’arcangelo et al., 2000). In
addition, a separate study found that pancreatic adenocarcinoma
cells produce VEGF in response to acidic pH (Shi et al., 2001).
The release of VEGF and bFGF in the tumor microenvironment
by tumor cells and endothelial cells may compensate for reduced
angiogenesis, and increase the rate of blood vessel growth in acidic
conditions.
In addition to angiogenesis acidosis also regulates vascular
tone. Acidosis-induced coronary arteriolar dilation is mediated
by ATP-sensitive potassium channels (Ishizaka et al., 1999).
Furthermore, acidosis can stimulate the inflammatory response
of vascular endothelial cells in which the pH-sensing GPR4 recep-
tor is involved (Chen et al., 2011; Dong et al., 2013).
pH-SENSING G PROTEIN-COUPLED RECEPTORS AND
TUMOR CELLS
As previously mentioned, the effects of acidosis on tumor cells
have been investigated; however, the molecular mechanisms that
facilitate these effects are largely unknown due to the complex-
ity of acidosis response. Proton-sensing GPCRs including GPR4,
TDAG8 (GPR65), OGR1 (GPR68), and G2A (GPR132) have
recently been identified as novel pH sensors that are proposed to
be activated by acidic extracellular pH through the protonation of
several histidine residues of these receptors (Ludwig et al., 2003;
Murakami et al., 2004; Wang et al., 2004; Ishii et al., 2005; Radu
et al., 2005; Seuwen et al., 2006; Yang et al., 2007; Liu et al., 2010b;
Sun et al., 2010; Saxena et al., 2012). Proton-sensing GPCRs may
play a role in tumor development, metastasis, inflammation, and
angiogenesis (Figure 2).
GPR4, stimulated by acidosis, has been reported to activate
the Gs, G12/13, and Gq G-protein pathways (Ludwig et al., 2003;
Tobo et al., 2007; Castellone et al., 2011; Chen et al., 2011).
When ectopically overexpressed in murine B16F10 melanoma
cells, activation of GPR4 by acidosis has several effects on tumor
cell function such as decreasing cell membrane protrusions,
inhibiting cancer cell migration, and reducing melanoma cell
lung metastasis through the G12/13/Rho pathway; whereas GPR4
does not significantly inhibit primary B16F10 melanoma growth
(Castellone et al., 2011; Zhang et al., 2012). The GPR4 deficiency
in mice, however, has been reported to reduce the growth of
tumor allografts by impairing angiogenesis from the host mice
(Wyder et al., 2011). It has also been shown that ectopic over-
expression of GPR4 can transform NIH3T3 fibroblast cells (Sin
et al., 2004). Collectively, both tumor-promoting and tumor-
suppressing effects of GPR4 have been reported, which may
depend on cell type and biological context.
OGR1, another family member, has been reported to suppress
metastasis when overexpressed in prostate cancer cells. Following
injection into the mouse prostate, PC3 prostate cancer cells that
overexpress OGR1 have markedly reduced metastasis to the lung,
spleen, and diaphragm (Singh et al., 2007). A separate study
found OGR1 expression is lower in distant metastatic lesions
in comparison to the primary tumor (Latulippe et al., 2002).
Furthermore, overexpression of OGR1 in HEY ovarian cancer
cells reduced cell migration and increased cell adhesion to sev-
eral extracellular matrix proteins (Ren and Zhang, 2011). Similar
effects of cancer metastasis suppression by GPR4 and OGR1 may
be due to the fact that they share the highest homology between
the members of the proton sensing GPCRs.
TDAG8 may also affect tumor development and growth. It has
been reported that the overexpression of TDAG8 in Lewis lung
carcinoma cells increases tumor growth in mice and may facil-
itate resistance to acidosis-mediated cell death in vitro through
protein kinase A (PKA) and ERK related pathways (Ihara et al.,
2010). In addition, knockdown of TDAG8 in NCI-H460 human
non-small cell lung cancer cells by shRNA decreases cell sur-
vival in acidic conditions (Ihara et al., 2010). TDAG8 activation
by acidosis also promotes evasion of cell apoptosis under glu-
tamine starvation (Ryder et al., 2012) and its overexpression
has been reported to transform immortalized mammary epithe-
lial cells (Sin et al., 2004). Alternatively, TDAG8 expression and
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FIGURE 2 | Major effects of the pH-sensing G protein-coupled receptors on tumor cells and associated stromal cells and immune cells.
activation stimulates glucocorticoid-induced apoptosis (Malone
et al., 2004) and inhibits c-Myc oncogene expression (Li et al.,
2013) in lymphoma cells and lymphocytes that have high level
of endogenous TDAG8 expression. Interestingly, the expression
of TDAG8 mRNA is decreased by more than 50% in human
lymphoma samples in comparison to non-tumorous lymphoid
tissues (Li et al., 2013).
Compared to GPR4, OGR1, and TDAG8, the pH-sensing func-
tion of G2A is less defined. Whereas the proton-sensing activity
can be detected in G2A-overexpressing cells, the receptor is dis-
pensable for acid sensing in native lymphocytes (Radu et al.,
2005). G2A was originally found to affect tumor development
and inhibit cell cycle progression at the G2/M stage, leading to G2
accumulation (G2A) and mitosis inhibition (Weng et al., 1998).
It is primarily expressed in immune cells and has been known to
mitigate BCR/ABL transformation in the mouse leukemia model
(Le et al., 2002). Alternatively, some studies indicate that G2A
has a transforming ability in NIH3T3 fibroblasts by leading to
loss of contact inhibition, anchorage independent growth, sur-
vival, and proliferation as well as increased tumorigenicity inmice
(Zohn et al., 2000). G2A may also affect the actin cytoskeleton
through Gα13 and stimulate RhoA dependent actin stress fiber
development in swiss 3T3 fibroblasts (Kabarowski et al., 2000).
In addition, G2A is mainly studied as an immune regulatory
GPCR due to the high expression in lymphoid tissues, which may
affect tumor immunology and therefore, possibly affect tumor
development and growth.
pH-SENSING G PROTEIN-COUPLED RECEPTORS AND
INFLAMMATION
GPR4, OGR1, TDAG8, and G2A have all been reported to regu-
late inflammatory responses (Mogi et al., 2009; Chen et al., 2011;
Onozawa et al., 2011, 2012; Yan et al., 2012; Dong et al., 2013).
Recent studies demonstrated that activation of GPR4 by acido-
sis induced a broad inflammatory response in human vascular
endothelial cells as revealed by microarray analysis (Dong et al.,
2013). Specifically, GPR4 activation by acidosis upregulates the
expression of adhesion molecules, pro-inflammatory cytokines
and chemokines, NF-κB pathway genes, and prostaglandin-
endoperoxidase synthase 2 (PTGS2 or COX2) (Chen et al., 2011;
Dong et al., 2013). Furthermore, both static cell adhesion assay
and flow chamber assay showed that acidosis-induced GPR4
activation leads to the increased endothelial cell adhesion with
leukocytes mainly through the Gs/cAMP/Epac pathway (Chen
et al., 2011; Dong et al., 2013).
OGR1 may be involved in tumor immune response. Yan et al.
recently demonstrated that OGR1 deficiency in host cells may sig-
nificantly reduce tumor allograft development of prostate cancer
cells in the OGR1 knockout mice (Yan et al., 2012). It was shown
in the same study that T cells are required for the rejection of inoc-
ulated tumor cells. The authors concluded that OGR1expression
in myeloid-derived cells is needed for the immunosuppression
induced by prostate cancer cells (Yan et al., 2012).
TDAG8 is highly expressed in immune cells. TDAG8 in mouse
peritoneal macrophages has been demonstrated to aid in the
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process of inhibiting cytokine production from extracellular acid-
ification (Mogi et al., 2009). In addition, TDAG8 deficiency
in mice intensifies the type II collagen-induced arthritis and
delayed-type hypersensitivity, which demonstrated that TDAG8
may be a negative regulator of the immune response (Onozawa
et al., 2011). A putative TDAG8 agonist has recently been iden-
tified (Onozawa et al., 2012). Studies showed that the TDAG8
agonist reduces the expression of IL-2 in mouse splenocytes stim-
ulated with anti-CD3 and anti-CD28 antibodies and reduces
TNF-α and IL-6 in mouse peritoneal macrophages stimulated
with lipopolysaccharide in vitro (Onozawa et al., 2012). In a pre-
vious study, TDAG8 was reported to play a role in glucocorticoid-
induced thymocyte apoptosis in the TDAG8 transgenic mouse
model (Tosa et al., 2003). More recently, however, a study demon-
strated TDAG8 deficiency does not affect immune system devel-
opment or glucocorticoid-induced thymocyte apoptosis in the
TDAG8 knockout mice (Radu et al., 2006). In eosinophils TDAG8
is the principal proton sensor (Kottyan et al., 2009). Its activity
has been demonstrated to increase eosinophil viability and reduce
apoptosis which may affect allergic airway disease (Kottyan et al.,
2009).
Whereas G2A is also highly expressed in leukocytes, its func-
tion in immune cell response to acidosis is unclear. A previous
study showed that the pH-sensing capability of G2A is much
weaker than other family members (Radu et al., 2006). Instead,
a number of reports demonstrated that G2A may mediate the
effects of bioactive lipids on immune cells. G2A is required for the
chemotaxis of T cells and macrophages toward lysophosphatidyl-
choline (Radu et al., 2004; Yang et al., 2005; Peter et al., 2008),
a pro-inflammatory molecule produced in apoptosis, atheroscle-
rosis and other processes. By increasing macrophage chemotaxis
to apoptotic cells G2A may suppress the induction of autoimmu-
nity and inflammation (Peter et al., 2008). G2A was also found to
be critical for the lysophosphatidylserine-stimulated clearance of
dying neutrophils by macrophages (Frasch et al., 2008). G2A may
also function as an anti-autoimmune receptor in mice as G2A-
null mice develop a late-onset autoimmune disorder in that G2A
may control peripheral lymphocyte homeostasis (Le et al., 2001).
Furthermore, acidosis in inflamed regions may lead to ele-
vated level of pain and increased sensitivity of nociceptors to
thermal andmechanical stimuli (Steen et al., 1992; Issberner et al.,
1996; Huang et al., 2007; Chen et al., 2009; Hang et al., 2012).
The amount of pain may be directly attributed to the amount of
acidification. All of the pH sensing GPCRs are expressed in pain
relevant loci such as the dorsal root ganglia neurons and particu-
larly small diameter neurons responsible for nociception (Huang
et al., 2007). These pH receptors such as TDAG8 and G2A may
function to sense high levels of protons for pain sensory and to
regulate the development of hyperalgesia (Chen et al., 2009). It
was also shown that TDAG8 and its downstream PKA pathway
are involved in sensing cancer pain in rats (Hang et al., 2012).
pH-SENSING G PROTEIN-COUPLED RECEPTORS AND
BLOOD VESSELS
As previously described, angiogenesis in tumors may result in the
abnormal development of blood vessels characterized by struc-
tural and functional defects (Fukumura and Jain, 2007; Nagy
et al., 2010). Furthermore, acidosis may inhibit the growth of
blood vessels but the addition of sufficient VEGF and bFGF can
rescue the vessel growth (Burbridge et al., 1999). GPR4 has been
investigated as one of the contributors to blood vessel growth by
regulating the expression of VEGF receptors (Wyder et al., 2011).
GPR4 also regulates the integrity and stability of blood vessels. A
fraction of GPR4 knockout mouse neonates have increasing rates
of spontaneous hemorrhage likely due to the abnormalities of
small blood vessels (Yang et al., 2007). Consistently, more fragile
and patchy blood vessels were observed in the tumors grown in
the GPR4 knockout mice in comparison to that in the wild type
mice (Wyder et al., 2011).
Another receptor, OGR1, has been implicated in vascular
smooth muscle function. OGR1 has been recently attributed as
a major receptor responsible for acidosis stimulation of PGI(2)
production and cAMP accumulation in human aortic smooth
muscle cells (Tomura et al., 2005). Moreover, OGR1 knockdown
with small interfering RNA inhibited acidosis-induced COX-2,
PGI(2), and MKP-1 expression in human aortic smooth muscle
cells (Liu et al., 2010a). These effects were further found to be
regulated by the G(q/11) G-protein signaling pathway (Liu et al.,
2010a).
THERAPEUTIC IMPLICATIONS: TARGETING THE ACIDIC
TUMOR MICROENVIRONMENT
As the tumor microenvironment is characteristically acidic,
molecular pathways involved in acid-base regulation and pH
homeostasis have been explored to devise new approaches for
cancer treatment (Izumi et al., 2003; Swietach et al., 2010; Webb
et al., 2011). For instance, several groups have recently found
that proton pump inhibitors may reduce neoplastic development
of esophageal adenocarcinoma and hepatoblastoma (Morimura
et al., 2008; Kastelein et al., 2013). In a five-year study a group
recognized that proton pump inhibitors such as omeprazole,
esomeprazole, rabeprazole, pantoprazole, or lansoprazole lead to
a significant reduction in the progression of neoplastic growth
and development in patients with Barrett’s esophagus (Kastelein
et al., 2013). In addition, another group showed that Bafilomycin
A1, a vacuolar-type proton pump inhibitor, increases apoptosis
in hepatoblastoma cells but not in normal cells, suggesting that it
may be a potential treatment to kill cancer cells (Morimura et al.,
2008).
Another method that has been tested is basic buffer ther-
apy. In the athymic nude mouse tumor model or TRAMP
prostate cancer mouse model, systemic basic buffer therapy was
used to increase the pH of the body and tumor microenvi-
ronment with the overall goal of reducing tumor development
and metastasis (Ibrahim Hashim et al., 2011; Ibrahim-Hashim
et al., 2012). Sodium bicarbonate was fed orally over a pro-
longed period of time, which reduced acidosis in the tumor
microenvironment as well as tumor growth, development, and
metastasis in the TRAMP mouse model (Ibrahim-Hashim et al.,
2012).
Acidosis in the tumor microenvironment has also been
exploited to specifically deliver cancer therapeutics and imag-
ing agents to the tumor sites (Vavere et al., 2009; Han et al.,
2013; Lin et al., 2013). For example, the use of acid-released
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nanoparticles, such as polyethylene glycol based hydrogels inte-
grated with imidazole and antagomir, or acid-released nanopar-
ticles carrying gene expression constructs, may increase cancer
therapy effectiveness by reducing the systemic effects normally
found in chemotherapy (Han et al., 2013; Lin et al., 2013). Recent
studies also demonstrate that a type of small peptide, the pH
low insertion peptide (pHLIP), can form an α-helix and insert
itself into cell membranes specifically at acidic pH. The pHLIP
has been used to exclusively deliver imaging agents to the acidic
tumor microenvironment for cancer detection in animal models
(Vavere et al., 2009).
Since GPCRs are important pharmaceutical targets (Jacoby
et al., 2006), modulation of the pH-sensing GPCRs may be
highly valuable in the field of cancer therapy and chemopre-
vention. As discussed in this review, proton-sensing GPCRs play
numerous roles in tumor cell behavior, inflammation, and blood
vessel growth. Manipulating the proton-sensing GPCRs or their
downstream signaling pathways may have anti-cancer therapeu-
tic applicability. Small molecule modulators of the pH-sensing
GPCRs are being actively developed and evaluated. Antagonists
of GPR4 and agonists of OGR1 and TDAG8 have recently been
identified, and these compounds show biological activities that
inhibit inflammation and block malignant astrocyte prolifera-
tion, among other activities (Taracido et al., 2009; Zhang et al.,
2011; Onozawa et al., 2012; Russell et al., 2012; Dong et al.,
2013). Moreover, recent progress in nanoparticle delivery of
gene expression constructs and oligonucleotides may provide
new avenues to target the pH-sensing GPCRs by exploiting the
unique acidic tumor microenvironment (Han et al., 2013; Lin
et al., 2013). Several reports have found that GPR4 and OGR1
may function as metastasis suppressors (Latulippe et al., 2002;
Singh et al., 2007; Castellone et al., 2011; Zhang et al., 2012).
Conceivably, acidic pH-released nanoparticles infused with gene
constructs to express the pH-sensing GPCRs, such as GPR4 and
OGR1, may be specifically delivered into the tumor microen-
vironment to further minimize systemic toxicity due to the
fact that these receptors are only active in acidic environments.
Whereas modulators of the proton sensing GPCRs may be of
some therapeutic benefit, limitations do exist. For instance, the
application of proton sensing G protein-coupled receptor mod-
ulators will not address all of the pathogenic issues that may
arise from acidosis or altered pH. Acidosis in general is a very
complex pathophysiological factor that has a broad effect on
various cell processes and functions. Moreover, there are mul-
tiple acid-base sensing and transport systems that tightly reg-
ulate pH homeostasis at the molecular and cellular level. This
makes uncovering specific mechanisms from altered pH and
targeting acidosis-related signaling pathways a potentially diffi-
cult task. Nonetheless, the implications for this family of proton
sensing GPCRs are ever expanding in tumor biology and may
prove crucial to understanding how tumor cells, immune cells,
and blood vessels sense and respond to acidosis in the tumor
microenvironment.
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